Trinity Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $15,152 | $15,843 | $13,428 | $14,704 |
Gross Profit | 5,308 | 5,734 | 4,107 | 4,995 |
EBITDA | -1,112 | -3,027 | -2,295 | |
EBIT | -1,710 | -3,489 | -2,986 | |
Net Income | -4,759 | -6,757 | -5,502 | -3,317 |
Net Change In Cash | 15,152 | 15,843 | 13,428 | 14,704 |
Free Cash Flow | -6,323 | -4,268 | -1,857 | -6,285 |
Cash | 5,317 | 3,691 | 5,776 | |
Basic Shares | 10,387 | 189,310 | 7,665 | 8,872 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $56,832 | $74,779 | $92,965 | $101,980 |
Gross Profit | 19,450 | 22,048 | 38,077 | 48,580 |
EBITDA | -24,098 | -16,713 | 10,592 | 21,523 |
EBIT | -25,874 | -19,046 | 7,848 | 18,446 |
Net Income | -24,018 | -41,002 | 875 | -6,013 |
Net Change In Cash | 56,832 | 74,779 | 92,965 | 101,980 |
Free Cash Flow | -14,261 | -6,898 | 4,547 | 13,557 |
Cash | 3,691 | 6,578 | 25,910 | 27,327 |
Basic Shares | 7,654 | 7,774 | 5,325 | 4,180 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.42 |
2024-06-30 | -$0.71 |
2024-03-31 | -$3.58 |
2023-12-31 | -$0.17 |
